Viveve Medical, Inc. (VIVE)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2021 | 1.47 Million USD | -54.76% |
| 2020 | 3.25 Million USD | -33.06% |
| 2019 | 4.86 Million USD | 18.01% |
| 2018 | 4.11 Million USD | 72.34% |
| 2017 | 2.39 Million USD | -11.05% |
| 2016 | 2.68 Million USD | 73.47% |
| 2015 | 1.54 Million USD | 1082.44% |
| 2014 | 131 Thousand USD | 11.97% |
| 2013 | 117 Thousand USD | -35.71% |
| 2012 | 182 Thousand USD | -23.53% |
| 2011 | 238 Thousand USD | -71.53% |
| 2010 | 836 Thousand USD | -4.57% |
| 2009 | 876 Thousand USD | -22.89% |
| 2008 | 1.13 Million USD | 33.33% |
| 2007 | 852 Thousand USD | -32.11% |
| 2006 | 1.25 Million USD | 30.32% |
| 2005 | 963 Thousand USD | -13.4% |
| 2004 | 1.11 Million USD | 25.65% |
| 2003 | 885 Thousand USD | -2.96% |
| 2002 | 912 Thousand USD | -8.89% |
| 2001 | 1 Million USD | -30.49% |
| 2000 | 1.44 Million USD | -38.67% |
| 1999 | 2.34 Million USD | -21.73% |
| 1998 | 3 Million USD | 20.0% |
| 1997 | 2.5 Million USD | 8.7% |
| 1996 | 2.3 Million USD | 27.78% |
| 1995 | 1.8 Million USD | 38.46% |
| 1994 | 1.3 Million USD | -18.75% |
| 1993 | 1.6 Million USD | -20.0% |
| 1992 | 2 Million USD | 0.0% |
| 1991 | - USD | 0.0% |
| 1990 | - USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2022 Q1 | 1.55 Million USD | 5.43% |
| 2022 Q3 | 1.61 Million USD | 1.0% |
| 2022 Q2 | 1.59 Million USD | 3.03% |
| 2021 Q4 | 1.47 Million USD | -31.53% |
| 2021 FY | 1.47 Million USD | -54.76% |
| 2021 Q1 | 3.04 Million USD | -6.3% |
| 2021 Q2 | 2.63 Million USD | -13.68% |
| 2021 Q3 | 2.15 Million USD | -18.31% |
| 2020 Q1 | 4.45 Million USD | -8.27% |
| 2020 Q3 | 4.59 Million USD | -6.63% |
| 2020 Q2 | 4.91 Million USD | 10.27% |
| 2020 FY | 3.25 Million USD | -33.06% |
| 2020 Q4 | 3.25 Million USD | -29.12% |
| 2019 Q1 | 3.86 Million USD | -6.12% |
| 2019 Q4 | 4.86 Million USD | 17.39% |
| 2019 FY | 4.86 Million USD | 18.01% |
| 2019 Q2 | 4.71 Million USD | 21.9% |
| 2019 Q3 | 4.14 Million USD | -12.16% |
| 2018 Q2 | 4.16 Million USD | 8.7% |
| 2018 Q1 | 3.82 Million USD | 60.17% |
| 2018 FY | 4.11 Million USD | 72.34% |
| 2018 Q4 | 4.11 Million USD | -8.41% |
| 2018 Q3 | 4.49 Million USD | 8.07% |
| 2017 Q1 | 2.38 Million USD | -11.31% |
| 2017 FY | 2.39 Million USD | -11.05% |
| 2017 Q4 | 2.39 Million USD | 25.59% |
| 2017 Q3 | 1.9 Million USD | -6.85% |
| 2017 Q2 | 2.04 Million USD | -14.27% |
| 2016 Q1 | 926 Thousand USD | -40.22% |
| 2016 Q2 | 845 Thousand USD | -8.75% |
| 2016 Q3 | 1.41 Million USD | 67.22% |
| 2016 Q4 | 2.68 Million USD | 90.16% |
| 2016 FY | 2.68 Million USD | 73.47% |
| 2015 Q3 | 645 Thousand USD | 91.39% |
| 2015 FY | 1.54 Million USD | 1082.44% |
| 2015 Q1 | 167 Thousand USD | 27.48% |
| 2015 Q4 | 1.54 Million USD | 140.16% |
| 2015 Q2 | 337 Thousand USD | 101.8% |
| 2014 Q4 | 131 Thousand USD | -4.31% |
| 2014 Q3 | 136.9 Thousand USD | 35.55% |
| 2014 Q2 | 101 Thousand USD | -9.82% |
| 2014 Q1 | 112 Thousand USD | -4.27% |
| 2014 FY | 131 Thousand USD | 11.97% |
| 2013 Q1 | 89 Thousand USD | -51.1% |
| 2013 Q3 | 145 Thousand USD | -9.94% |
| 2013 Q2 | 161 Thousand USD | 80.9% |
| 2013 FY | 117 Thousand USD | -35.71% |
| 2013 Q4 | 117 Thousand USD | -19.31% |
| 2012 Q1 | 219 Thousand USD | -7.98% |
| 2012 Q4 | 182 Thousand USD | -22.55% |
| 2012 Q3 | 235 Thousand USD | 17.5% |
| 2012 Q2 | 200 Thousand USD | -8.68% |
| 2012 FY | 182 Thousand USD | -23.53% |
| 2011 FY | 238 Thousand USD | -71.53% |
| 2011 Q4 | 238 Thousand USD | 19.0% |
| 2011 Q3 | 200 Thousand USD | 29.87% |
| 2011 Q2 | 154 Thousand USD | -52.91% |
| 2011 Q1 | 327 Thousand USD | -60.89% |
| 2010 Q4 | 836 Thousand USD | 6.91% |
| 2010 Q1 | 801 Thousand USD | -8.56% |
| 2010 FY | 836 Thousand USD | -4.57% |
| 2010 Q2 | 795 Thousand USD | -0.75% |
| 2010 Q3 | 782 Thousand USD | -1.64% |
| 2009 FY | 876 Thousand USD | -22.89% |
| 2009 Q1 | 1.03 Million USD | -9.33% |
| 2009 Q2 | 978 Thousand USD | -5.05% |
| 2009 Q3 | 945 Thousand USD | -3.37% |
| 2009 Q4 | 876 Thousand USD | -7.3% |
| 2008 Q1 | 1.43 Million USD | 68.19% |
| 2008 Q2 | 1.41 Million USD | -1.05% |
| 2008 Q4 | 1.13 Million USD | -0.7% |
| 2008 FY | 1.13 Million USD | 33.33% |
| 2008 Q3 | 1.14 Million USD | -19.32% |
| 2007 FY | 852 Thousand USD | -32.11% |
| 2007 Q2 | 990 Thousand USD | -8.08% |
| 2007 Q4 | 852 Thousand USD | -0.35% |
| 2007 Q3 | 855 Thousand USD | -13.64% |
| 2007 Q1 | 1.07 Million USD | -14.18% |
| 2006 Q2 | 986 Thousand USD | -1.0% |
| 2006 Q1 | 996 Thousand USD | 3.43% |
| 2006 FY | 1.25 Million USD | 30.32% |
| 2006 Q4 | 1.25 Million USD | 7.82% |
| 2006 Q3 | 1.16 Million USD | 18.05% |
| 2005 Q1 | 1.27 Million USD | 15.02% |
| 2005 Q4 | 963 Thousand USD | -2.23% |
| 2005 Q2 | 1.14 Million USD | -10.4% |
| 2005 FY | 963 Thousand USD | -13.4% |
| 2005 Q3 | 985 Thousand USD | -14.05% |
| 2004 Q3 | 1.33 Million USD | 16.38% |
| 2004 FY | 1.11 Million USD | 25.65% |
| 2004 Q1 | 836 Thousand USD | -5.54% |
| 2004 Q2 | 1.14 Million USD | 37.32% |
| 2004 Q4 | 1.11 Million USD | -16.77% |
| 2003 FY | 885 Thousand USD | -2.96% |
| 2003 Q4 | 885 Thousand USD | -20.98% |
| 2003 Q3 | 1.12 Million USD | 2.28% |
| 2003 Q2 | 1.09 Million USD | 3.5% |
| 2003 Q1 | 1.05 Million USD | 16.01% |
| 2002 Q2 | 946 Thousand USD | 9.24% |
| 2002 Q1 | 866 Thousand USD | -13.49% |
| 2002 FY | 912 Thousand USD | -8.89% |
| 2002 Q4 | 912 Thousand USD | 0.66% |
| 2002 Q3 | 906 Thousand USD | -4.23% |
| 2001 Q3 | 1.31 Million USD | -0.23% |
| 2001 Q2 | 1.32 Million USD | -10.13% |
| 2001 Q1 | 1.47 Million USD | 2.15% |
| 2001 FY | 1 Million USD | -30.49% |
| 2001 Q4 | 1 Million USD | -24.11% |
| 2000 Q4 | 1.44 Million USD | -14.54% |
| 2000 Q2 | 1.82 Million USD | -14.09% |
| 2000 Q1 | 2.12 Million USD | -9.63% |
| 2000 FY | 1.44 Million USD | -38.67% |
| 2000 Q3 | 1.68 Million USD | -7.57% |
| 1999 Q3 | 1.6 Million USD | -27.27% |
| 1999 FY | 2.34 Million USD | -21.73% |
| 1999 Q1 | 3 Million USD | 0.0% |
| 1999 Q2 | 2.2 Million USD | -26.67% |
| 1999 Q4 | 2.34 Million USD | 46.75% |
| 1998 Q2 | 3.9 Million USD | 30.0% |
| 1998 Q4 | 3 Million USD | -23.08% |
| 1998 Q3 | 3.9 Million USD | 0.0% |
| 1998 Q1 | 3 Million USD | 20.0% |
| 1998 FY | 3 Million USD | 20.0% |
| 1997 Q2 | 3.1 Million USD | -3.13% |
| 1997 Q3 | 3.2 Million USD | 3.23% |
| 1997 Q4 | 2.5 Million USD | -21.88% |
| 1997 FY | 2.5 Million USD | 8.7% |
| 1997 Q1 | 3.2 Million USD | 39.13% |
| 1996 Q2 | 2.9 Million USD | 45.0% |
| 1996 Q3 | 3.2 Million USD | 10.34% |
| 1996 Q4 | 2.3 Million USD | -28.13% |
| 1996 FY | 2.3 Million USD | 27.78% |
| 1996 Q1 | 2 Million USD | 11.11% |
| 1995 FY | 1.8 Million USD | 38.46% |
| 1995 Q4 | 1.8 Million USD | 0.0% |
| 1994 Q2 | 1.6 Million USD | 14.29% |
| 1994 Q3 | 1.5 Million USD | -6.25% |
| 1994 FY | 1.3 Million USD | -18.75% |
| 1994 Q4 | 1.3 Million USD | -13.33% |
| 1994 Q1 | 1.4 Million USD | -12.5% |
| 1993 Q2 | 2.4 Million USD | 14.29% |
| 1993 Q4 | 1.6 Million USD | -27.27% |
| 1993 Q3 | 2.2 Million USD | -8.33% |
| 1993 FY | 1.6 Million USD | -20.0% |
| 1993 Q1 | 2.1 Million USD | 5.0% |
| 1992 FY | 2 Million USD | 0.0% |
| 1992 Q3 | 2.5 Million USD | 4.17% |
| 1992 Q4 | 2 Million USD | -20.0% |
| 1992 Q2 | 2.4 Million USD | 26.32% |
| 1992 Q1 | 1.9 Million USD | 0.0% |
| 1991 FY | - USD | 0.0% |
| 1991 Q4 | - USD | 0.0% |
| 1990 FY | - USD | 0.0% |
| 1990 Q4 | - USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Acutus Medical, Inc. | 4.27 Million USD | 65.591% |
| Biotricity, Inc. | 1.87 Million USD | 21.677% |
| Cell MedX Corp. | - USD | -Infinity% |
| Dynatronics Corporation | 5.59 Million USD | 73.686% |
| Nemaura Medical Inc. | 1.75 Million USD | 16.118% |
| PetVivo Holdings, Inc. | 390.07 Thousand USD | -277.362% |
| RetinalGenix Technologies Inc. | - USD | -Infinity% |
| Sonendo, Inc. | 11.07 Million USD | 86.708% |
| Telesis Bio, Inc. | 4.02 Million USD | 63.429% |
| Talis Biomedical Corporation | - USD | -Infinity% |